IL2112

N/A

Report date: 2024/08/21 14:44:24

Base Information

Drug NameIL2112
Drug Alias NameIL2112IL-2112
ClassificationOther
Mechanisms of ActionC-X-C chemokine receptor type 7 agonists
TargetsC-X-C chemokine receptor type 7
Therapy Area/IndicationsFibrosisAutoimmune DiseasesAmyotrophic Lateral Sclerosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesiLeadBMS Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesiLeadBMS Co Ltd
Inactive CompaniesN/A
Active IndicationsFibrosisAutoimmune DiseasesAmyotrophic Lateral Sclerosis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A